NeoGenomics (NASDAQ:NEO) reported Q4 2017 earnings this Morning, coming in at $0.05 per share, beating Wall Street’s estimates of $0.04 per Share. Revenue for the quarter came in at $67.79 million beating analyst estimates of $66.32 million Recent Insider Trading for NeoGenomics (NASDAQ:NEO)
- On 7/27/2017 Alison L Hannah, Director, bought 20,000 with an average share price of $9.19 per share and the total transaction amounting to $183,800.00.
- On 6/22/2017 Jennifer Balliet, VP, sold 10,723 with an average share price of $8.49 per share and the total transaction amounting to $91,038.27.
- On 6/5/2017 Steven A Ross, Insider, sold 70,833 with an average share price of $7.76 per share and the total transaction amounting to $549,664.08.
- On 5/26/2017 Jennifer Balliet, VP, sold 3,334 with an average share price of $7.50 per share and the total transaction amounting to $25,005.00.
- On 3/20/2017 Steven G Brodie, Insider, sold 50,000 with an average share price of $7.93 per share and the total transaction amounting to $396,500.00.
- On 9/23/2016 Maher Albitar, Insider, sold 2,800 with an average share price of $8.40 per share and the total transaction amounting to $23,520.00.
Recent Trading for NeoGenomics (NASDAQ:NEO) Shares of NeoGenomics closed the previous trading session at 7.35 down -0.01 0.14% with 7.349999904632568 shares trading hands.